Genky DrugStores Co.,Ltd. [9267.T]
TOKYO, Apr 28 (Pulse News Wire) – Genky Drugstores Co., Ltd. (9267.T) reported consolidated results for Q3 FY2026 (ending June 2026).
Revenue was ¥160 billion (+9.7% YoY). operating profit was ¥8,022 million (+17.3%). net profit attributable to shareholders was ¥5,621 million (+15.4%).
Total assets stood at ¥140 billion with an equity ratio of 41.4%. The company declared an annual dividend of ¥6 per share. The full-year forecast for the current fiscal year is revenue of ¥220 billion (+10.2%).
Financial results — FY2026/6 (consolidated)
| Metric | Current | YoY |
|---|---|---|
| Revenue | ¥161,710M | +9.7% |
| Operating profit | ¥8,022M | +17.3% |
| Net profit | ¥5,621M | +15.4% |
Next period forecast
Revenue
¥221,200M
+10.2%Op. profit
¥11,050M
+14.4%Net profit
¥7,850M
+11.1%Source: TDNet filing · Figures in millions of yen
🟢 Confidence: High AI-translated content.